Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients
Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients
Not yet recruiting · NCT06908772 · Registry updated 2025-04-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Not yet recruiting | Phase 2 / Phase 3 | 2025-04-03 | NCT06908772 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai JMT-Bio Inc. | 30 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||